Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,441–3,448 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Quince Therapeutics Inc. eDSP Ataxia-Telangiectasia Phase 3 Data Released oral Genetic Disorder
Quince Therapeutics Inc. EryDex (dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP)) - (NEAT) Ataxia-Telangiectasia (A-T) Phase 3 Data Released Intravenous Genetic Disorder
Quince Therapeutics Inc. Atuzaginstat - (GAIN) Alzheimer’s disease Phase 2/3 Trial Discontinued Oral Neurology
Quince Therapeutics Inc. Atuzaginstat Oral potentially malignant disorders (OPMD) Phase 2 Looking for Funding Oral Oncology
Quince Therapeutics Inc. Atuzaginstat Parkinson's disease Phase 2 Trial Discontinued Oral Neurology
Quoin Pharmaceuticals Ltd. QRX003 - (CL-QRX003-002) Netherton Syndrome Phase 3 Ongoing Topical Genetic Disorder
Radiopharm Theranostics Limited RAD 101 Brain Mets Phase 2b Data Released Oral Oncology
Rafael Holdings Inc. Class B Trappsol Cyclo - (TransportNPC) Niemann-Pick Disease Type C Phase 3 Ongoing Intravenous Genetic Disorder